Original Research January 19, 2026

Geographic Differences in Cannabis Use and Cannabis Use Disorder in the US Veteran Population

; ; ; ; ;

J Clin Psychiatry 2026;87(1):25m16141

Abstract

Objective: To examine regional differences in cannabis use and probable cannabis use disorder (CUD) in US veterans.

Methods: Participants (N = 2,441) were drawn from a nationally representative sample of US veterans who participated in the 2022 National Health and Resilience in Veterans Study, conducted from August 11 to September 12, 2022. Weighted estimates indicated that 85.5% reported no cannabis use, 11.6% reported cannabis use, and 2.9% screened positive for probable CUD. Chi-square tests were conducted to assess differences in cannabis use and probable CUD across 9 US Census Bureau–defined regions: New England, Middle Atlantic, East and West North Central, South Atlantic, East and West South Central, Mountain, and Pacific.

Results: Significant regional differences were observed in cannabis use and CUD across the 9 regions (χ216 = 73.33, P < .001). Veterans in the Pacific region exhibited the highest rates of cannabis use (18.6%) compared to all other regions except New England (8.2%–13.4%, Ps < .05). The Pacific region also had significantly higher rates of probable CUD (8.8%) relative to all other regions (0.7%–3.5%, Ps < .05).

Conclusion: These findings demonstrate substantial regional differences in cannabis use and probable CUD among US veterans and underscore the importance of routine screening for cannabis-related problems in health care settings serving veterans, particularly in higher-prevalence regions of the United States.

J Clin Psychiatry 2026;87(1):25m16141

Author affiliations are listed at the end of this article.

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you’re already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

  1. Kevorkian S, Bonn-Miller MO, Belendiuk K, et al. Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychol Addict Behav. 2015;29(3):633–638. PubMed CrossRef
  2. Hill ML, Nichter BM, Norman SB, et al. Burden of cannabis use and disorder in the U.S. veteran population: psychiatric comorbidity, suicidality, and service utilization. J Affect Disord. 2021;278:528–535. PubMed CrossRef
  3. Hill ML, Loflin M, Nichter B, et al. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: results from the 2019-2020 National Health and Resilience in Veterans Study. Addict Behav. 2021;120:106963. PubMed CrossRef
  4. Cerdá M, Mauro C, Hamilton A, et al. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA Psychiatry. 2020;77(2):165–171. PubMed CrossRef
  5. Hasin DS, Wall MM, Choi CJ, et al. State cannabis legalization and cannabis use disorder in the US Veterans Health Administration, 2005 to 2019. JAMA Psychiatry. 2023;80(4):380–388. PubMed CrossRef
  6. Bonn-Miller MO, Heinz AJ, Smith EV, et al. Preliminary development of a brief cannabis use disorder screening tool: the Cannabis Use Disorder Identification Test Short-Form. Cannabis Cannabinoid Res. 2016;1(1):252–261. PubMed CrossRef
  7. Hardy SE, Gill TM. Recovery from disability among community-dwelling older persons. JAMA. 2004;291(13):1596–1602. PubMed CrossRef
  8. Choi NG, Moore J, Choi BY. Cannabis use disorder and substance use treatment among U.S. adults. J Subst Use Addict Treat. 2024;167:209486. PubMed CrossRef
  9. National Survey on Drug Use and Health. State Estimates of Substance Use and Mental Disorders. SAMHSA; 2025. Accessed July 5, 2025. https://datatools.samhsa.gov/saes/state.
  10. Jayawardhana J, Hou J, Freeman P, et al. Association of state cannabis legalization with cannabis use disorder and cannabis poisoning. JAMA Psychiatry. 2025;82(3):228–236. PubMed CrossRef
  11. Mattingly DT, Richardson MK, Hart JL. Prevalence of and trends in current cannabis use among US youth and adults, 2013–2022. Drug Alcohol Depend Rep. 2024;12:100253. PubMed CrossRef
  12. Meffert BN, Morabito DM, Sawicki DA, et al. US Veterans who do and do not utilize veterans affairs health care services: demographic, military, medical, and psychosocial characteristics. Prim Care Companion CNS Disord. 2019;21(1):18m02350. PubMed CrossRef
  13. Kansagara D, Morasco BJ, Iacocca MO, et al. Clinician knowledge, attitudes, and practice regarding cannabis: results from a National Veterans Health Administration Survey. Pain Med. 2020;21(11):3180–3186. PubMed CrossRef
  14. Bobitt J, Berryman K, Weaver FM. VA providers’ perceptions of cannabis use policies in a legalized and nonlegalized state. Cannabis Cannabinoid Res. 2025;10(1):e176–e183. PubMed CrossRef